Fundación Fls De Lucha Contra El Sida, Las Enfermedades Infecciosas Y La Promoción De La Salud Y La Ciencia
Clinical trials sponsored by Fundación Fls De Lucha Contra El Sida, Las Enfermedades Infecciosas Y La Promoción De La Salud Y La Ciencia, explained in plain language.
-
Can an arthritis drug shrink hidden HIV reservoirs?
Disease control OngoingThis study tests whether baricitinib, a drug used for arthritis, can safely reduce the hidden HIV reservoirs in people whose HIV is already well-controlled with standard medication. Thirty adults with suppressed HIV will take either baricitinib or a placebo daily for 12 weeks whi…
Phase: PHASE2 • Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
Could a common plant heal skin sores where medicine is scarce?
Symptom relief OngoingThis study tests whether a plant medicine made from Pterocarpus indicus can help heal small skin ulcers in people living in remote parts of Papua New Guinea. About 222 participants with sores smaller than 1 cm will use either the plant treatment, Savlon cream, or no treatment. He…
Phase: PHASE2 • Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Symptom relief
Last updated May 26, 2026 08:29 UTC
-
Could an HIV drug slow memory decline? new study investigates
Symptom relief OngoingThis pilot study tests whether lamivudine, an HIV medication, can reduce brain-damage markers in people with mild cognitive impairment (MCI) and early Alzheimer's signs. Twenty-three participants will take the drug for 24 weeks. The goal is to see if it lowers certain proteins in…
Phase: PHASE2 • Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Symptom relief
Last updated May 22, 2026 13:53 UTC